315 related articles for article (PubMed ID: 35069542)
1. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.
Xie YZ; Peng CW; Su ZQ; Huang HT; Liu XH; Zhan SF; Huang XF
Front Immunol; 2021; 12():769011. PubMed ID: 35069542
[TBL] [Abstract][Full Text] [Related]
2. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
3. Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets.
Ye Y; Huang Z; Chen M; Mo Y; Mo Z
Front Endocrinol (Lausanne); 2021; 12():802447. PubMed ID: 35178029
[TBL] [Abstract][Full Text] [Related]
4. Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking.
Tianyu Z; Liying G
Bioengineered; 2021 Dec; 12(1):2274-2287. PubMed ID: 34077310
[TBL] [Abstract][Full Text] [Related]
5. Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy.
Wang M; Fu D; Yao L; Li J
Comb Chem High Throughput Screen; 2021; 24(2):294-305. PubMed ID: 32767929
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics and experimental findings reveal the therapeutic actions and targets of pachymic acid against cystitis glandularis.
Feng Z; Shi H; Liang B; Ge T; Cai M; Liu F; Huang K; Wen J; Chen Q; Ge B
Biofactors; 2021 Jul; 47(4):665-673. PubMed ID: 33893687
[TBL] [Abstract][Full Text] [Related]
7. A network pharmacology strategy to investigate the anti-inflammatory mechanism of luteolin combined with in vitro transcriptomics and proteomics.
Huang XF; Zhang JL; Huang DP; Huang AS; Huang HT; Liu Q; Liu XH; Liao HL
Int Immunopharmacol; 2020 Sep; 86():106727. PubMed ID: 32593158
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.
Xia QD; Xun Y; Lu JL; Lu YC; Yang YY; Zhou P; Hu J; Li C; Wang SG
Cell Prolif; 2020 Dec; 53(12):e12949. PubMed ID: 33140889
[TBL] [Abstract][Full Text] [Related]
9. Network Pharmacology-Based Identification of Potential Targets of
Guo X; Yu X; Zheng B; Zhang L; Zhang F; Zhang Y; Li J; Pu G; Zhang L; Wu H
Biomed Res Int; 2021; 2021():5507003. PubMed ID: 34595237
[No Abstract] [Full Text] [Related]
10. Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation.
Zhuang Z; Zhong X; Zhang H; Chen H; Huang B; Lin D; Wen J
Comb Chem High Throughput Screen; 2021; 24(9):1377-1394. PubMed ID: 33135607
[TBL] [Abstract][Full Text] [Related]
11. Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19.
Zhao J; Tian S; Lu D; Yang J; Zeng H; Zhang F; Tu D; Ge G; Zheng Y; Shi T; Xu X; Zhao S; Yang Y; Zhang W
Phytomedicine; 2021 May; 85():153315. PubMed ID: 32978039
[TBL] [Abstract][Full Text] [Related]
12. Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks.
Xu J; Abdulsalam Khaleel R; Zaidan HK; Faisal Mutee A; Fahmi Fawy K; Gehlot A; Abbas AH; Arias Gonzáles JL; Amin AH; Ruiz-Balvin MC; Imannezhad S; Bahrami A; Akhavan-Sigari R
Cell Cycle; 2024 Feb; 23(4):405-434. PubMed ID: 38640424
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of the anti-inflammatory effects of Sophorae Flavescentis Aiton identified by network pharmacology.
Zhu N; Hou J
Sci Rep; 2021 Jan; 11(1):1005. PubMed ID: 33441867
[TBL] [Abstract][Full Text] [Related]
14. Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19).
Li X; Qiu Q; Li M; Lin H; Cao S; Wang Q; Chen Z; Jiang W; Zhang W; Huang Y; Luo H; Luo L
Aging (Albany NY); 2021 Feb; 13(4):4811-4830. PubMed ID: 33581688
[TBL] [Abstract][Full Text] [Related]
15. Virtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Coronavirus Infection.
Ping F; Wang Y; Shen X; Tan C; Zhu L; Xing W; Xu J
Med Sci Monit; 2022 Jan; 28():e934102. PubMed ID: 35075100
[TBL] [Abstract][Full Text] [Related]
16. Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma.
Huang R; Xu M; Guo W; Cheng M; Dong R; Tu J; Xu S; Zou C
Cancer Cell Int; 2023 Sep; 23(1):213. PubMed ID: 37749554
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6.
Niu WH; Wu F; Cao WY; Wu ZG; Chao YC; Liang C
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33146673
[TBL] [Abstract][Full Text] [Related]
18. New tale on LianHuaQingWen: IL6R/IL6/IL6ST complex is a potential target for COVID-19 treatment.
Tianyu Z; Xiaoli C; Yaru W; Min Z; Fengli Y; Kan H; Li C; Jing L
Aging (Albany NY); 2021 Nov; 13(21):23913-23935. PubMed ID: 34731090
[TBL] [Abstract][Full Text] [Related]
19. Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology.
Du HX; Zhu JQ; Chen J; Zhou HF; Yang JH; Wan HT
Aging (Albany NY); 2021 Jun; 13(11):14571-14589. PubMed ID: 34088885
[TBL] [Abstract][Full Text] [Related]
20. [Anti-inflammatory material basis and mechanism of Artemisia stolonifera based on UPLC-Q-TOF-MS combined with network pharmacology and molecular docking].
Chen L; Zhu YY; Kang LP; Guo CW; Wang YQ; Li SG; DU HZ; Liu DH
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3701-3714. PubMed ID: 37475061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
